Indivior PLC — Director's Dealing 2026

Feb 12, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Indivior Pharmaceuticals, Inc. (INDV)
CIK: 0001625297
Period of Report: 2026-02-10

Reporting Person: Ciaffoni Joseph (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-10	Common Stock	A	79976	—	Acquired	135976	Direct

Footnotes

F1: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.